XEROX CORPORATION — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/40b2b20b-70e8-4569-b330-12462ad50521/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $9.8B | 2018-01-01 – 2018-12-31 | evidence 0000108772-19-000011 |
| FY 2017 | $10.3B | 2017-01-01 – 2017-12-31 | evidence 0000108772-19-000011 |
| FY 2016 | $10.8B | 2016-01-01 – 2016-12-31 | evidence 0000108772-19-000011 |
| FY 2015 | $4.7B | 2015-01-01 – 2015-12-31 | evidence 0000108772-18-000012 |
| FY 2014 | $12.3B | 2014-01-01 – 2014-12-31 | evidence 0000108772-17-000008 |
| FY 2013 | $19.5B | 2013-01-01 – 2013-12-31 | evidence 0000108772-15-000005 |
| FY 2012 | $19.8B | 2012-01-01 – 2012-12-31 | evidence 0000108772-15-000005 |
| FY 2011 | $21.3B | 2011-01-01 – 2011-12-31 | evidence 0000108772-14-000005 |
| FY 2010 | $7.2B | 2009-12-31 – 2010-12-31 | evidence 0001445305-12-000425 |
| FY 2009 | $6.6B | 2008-12-31 – 2009-12-31 | evidence 0001445305-12-000425 |
| FY 2008 | $8.3B | 2008-01-01 – 2008-12-31 | evidence 0001193125-10-043079 |
| FY 2007 | $8.2B | 2007-01-01 – 2007-12-31 | evidence 0001193125-10-043079 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
XEROX CORPORATION — all facts · Net Income · Operating Income